Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 75 /hr
Hire Dr. Vinayak Khattar, P.
United States
USD 75 /hr
PhD & MBA powered Analyst, Consultant, & Medical Writer with broad experience in Life Sciences & expertise in Oncology
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Technical Writing,
Newswriting
Research
Fact Checking,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Product Development
Formulation
Work Experience
Consultant | Medical Content Developer
iNDX.Ai - Cupertino, California, US
January 2019 - Present
Science Writer | Technology Consultant | Global Scholar
PreScouter - Chicago, Illinois, US
October 2018 - Present
Science Writer
Acematiks Inc, Toronto, Canada
September 2018 - Present
Medical Content Writer
Medical News Bulletin (Wilderman Medical Clinic), Vaughan, Ontario, Canada
January 2018 - Present
Consultant
SmartAnalyst Inc, New York, U.S.
April 2016 - Present
Postdoctoral Research Scientist
University of Alabama at Birmingham
June 2015 - Present
Science Writer
BioNews Services
February 2019 - June 2019
Graduate Research
University of Alabama at Birmingham
August 2009 - May 2015
Education
Masters in Business Administration (M.B.A.)
University of Alabama at Birmingham
August 2015 - August 2017
Ph.D. - Biomedical Sciences (Cancer Biology)
University of Alabama at Birmingham
August 2009 - May 2015
Masters in Tehcnology (M.Tech) - Biotechnology
D.Y. Patil University
June 2004 - June 2009
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
(2018). Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity . Molecular therapy oncolytics.
(2018). Structural determinants and genetic modifications enhance BMP2 stability and extracellular secretion . FASEB bioAdvances.
(2018). Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations . Laboratory investigation; a journal of technical methods and pathology.
(2017). Location of tumor affects local and distant immune cell type and number . Immunity, inflammation and disease.
(2014). Cks1 proteasomal degradation is induced by inhibiting Hsp90-mediated chaperoning in cancer cells . Cancer chemotherapy and pharmacology.
(2014). Cks1 proteasomal turnover is a predominant mode of regulation in breast cancer cells: role of key tyrosines and lysines . International journal of oncology.
(2013). Cks1: Structure, Emerging Roles and Implications in Multiple Cancers . Journal of cancer therapy.